HCC Response Assessment by MRI After SBRT

Completed

• Conditions: Carcinoma, Hepatocellular

• Registration Number: NCT03088423
• Lead Sponsor: Institut de Cancérologie de Lorraine

Brief Summary

The aim of this work was to describe SBRT different presentations, to study predictive factors for tumor responses following treatment, and to compare tumor response assessments according to the Response Evaluation Criteria

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10-01
• Primary Completion: 2013-04-01
• Study Completion: 2015-02-01
• Status Verified: 2017-03
• Study First Submitted: 2017-03-16
• Study First Submitted QC: 2017-03-17
• Last Update Submitted: 2017-03-17
• Study First Posted: 2017-03-23
• Last Update Posted: 2017-03-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

the standard criteria for treating HCC patients with SBRT : an Eastern Cooperative Oncology Group (ECOG) score of 2, inoperable tumors (e.g. the patient being unfit for surgery, or tumor-related contraindications), and a maximum tumor diameter of 6 cm. The HCC diagnosis could be histological or based on the radiological criteria of the American Association for the Study of Liver Diseases (AASLD) *

Exclusion Criteria

no follow-up by MR imaging

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
tumor response assessments	Within the 24 months after SBRT	The tumor response was evaluated by the Response Evaluation Criteria in Solid Tumors (RECIST) v1.1